Nguyen Minh Tuan

Emailtuank67a5gmailcom

h-index

Research activity per year

Fingerprint

Dive into the research topics where Nguyen Minh Tuan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs
Van, N. T. H. & Nguyen, M. T., May 2025, In: Current Issues in Molecular Biology. 47, 5, 315.
Research output: Contribution to journal › Article › peer-review

Open Access
ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression
Park, M. K., Lee, H. J., Sung, J. Y., Byun, H. J., Kim, H. J., Kim, E. J., Nguyen, T. M., Kang, G. J., Oh, S. H., Shim, J. G., Lee, H., Nam, K. T., Kim, Y. Y., Rho, S. B., Kim, S. G. & Lee, C. H., Dec 2025, In: Cell Communication and Signaling. 23, 1, 204.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1–NRF2 interaction
Nguyen, M. T., Lee, G. J., Kim, B., Kim, H. J., Tak, J., Park, M. K., Kim, E. J., Kang, G. J., Rho, S. B., Lee, H., Lee, K., Kim, S. G. & Lee, C. H., Dec 2024, In: Pharmacological Research. 210, 107512.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Regulatory Mechanisms Governing the Autophagy-Initiating VPS34 Complex and Its inhibitors
Lee, Y., Tuan, N. M., Lee, G. J., Kim, B., Park, J. H. & Lee, C. H., 2024, In: Biomolecules and Therapeutics. 32, 6, p. 723-735 13 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
7 Scopus citations
Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling
Rahman, M., Nguyen, T. M., Lee, G. J., Kim, B., Park, M. K. & Lee, C. H., Feb 2024, In: International Journal of Molecular Sciences. 25, 3, 1489.
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Scopus citations

Dongguk University Researchers Describe New Findings in Liver Cancer (Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1-NRF2 interaction)
Lee, C. H., Kang, T. J., Lee, H. J., Lee, H. K. & Tuan, N. M.
24/12/24
1 item of Media coverage
Press/Media

Nguyen Minh Tuan

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs

ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression

Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1–NRF2 interaction

Regulatory Mechanisms Governing the Autophagy-Initiating VPS34 Complex and Its inhibitors

Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling

Dongguk University Researchers Describe New Findings in Liver Cancer (Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1-NRF2 interaction)

Nguyen Minh Tuan

Fingerprint

Collaborations and top research areas from the last five years

Research output

A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs

ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression

Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1–NRF2 interaction

Regulatory Mechanisms Governing the Autophagy-Initiating VPS34 Complex and Its inhibitors

Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling

Press/Media

Dongguk University Researchers Describe New Findings in Liver Cancer (Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1-NRF2 interaction)